Markets

Coherus Biosciences (CHRS) in Focus: Stock Surges 10.7% - Tale of the Tape

Highs and Lows Stock Data

Coherus Biosciences, Inc. ( CHRS ) was a big mover last session, as the company saw its shares surge around 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up 19.1% in the past one-month time frame.

None of the estimates for this biotechnology stock were revised over the past 30 days. The Zacks Consensus Estimate also remained unchanged over the same time frame. Yesterday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Coherus Biosciences currently carries a Zacks Rank #4 (Sell), while its Earnings ESP is 0.00%.

A better-ranked stock in the same industry is Achillion Pharmaceuticals, Inc. ( ACHN ), sporting a Zacks Rank #1 (Strong Buy).

Is CHRS going up? Or down? Predict to see what others think: Up or Down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

COHERUS BIOSC (CHRS): Free Stock Analysis Report

ACHILLION PHARM (ACHN): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

CHRS

Other Topics

Investing Stocks

Latest Markets Videos

    Zacks

    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

    Learn More